INTRODUCTION {#s0}
============

In 1911, the first study using the domestic ferret, Mustela putorius *furo*, for biomedical research was published ([@B1]). Since then, the ferret has been an invaluable model for cardiac research ([@B2]), spinal cord injury ([@B3]), epilepsy ([@B4]), and several lung conditions, including smoke-induced chronic obstructive pulmonary disease (COPD) ([@B5]), cystic fibrosis ([@B6]), and tobacco-induced lung cancer ([@B7]). The recent development of a database of the anatomical connections and structural features of the ferret brain will likely also improve the relevance of this model for neurological research ([@B8]). Yet, the ferret model is most widely recognized for its utility in infectious disease research, especially respiratory infections ([Table 1](#tab1){ref-type="table"}). A variety of human pathogens are known to naturally infect ferrets and often reproduce human disease better than mouse models. In this article, we discuss the recent advances and ongoing initiatives to increase the utility of the ferret model for biomedical research.

###### 

Human microbes used in the ferret model

  Pathogen group and species                          Reference(s)
  --------------------------------------------------- ----------------
  Viruses                                             
      Influenza virus                                 [@B26]
      Respiratory syncytial virus                     [@B27], [@B28]
      *Metapneumovirus*                               [@B29]
      Measles virus                                   [@B30]
      Mumps virus                                     [@B31], [@B32]
      Parainfluenza viruses                           [@B33], [@B34]
      Severe acute respiratory syndrome coronavirus   [@B35]
      Nipah virus                                     [@B36]
      Ebola virus                                     [@B37]
      Rift Valley fever virus                         [@B38]
  Bacteria                                            
      *Streptococcus* spp.                            [@B39]
      Staphylococcus aureus                           [@B40]
      Helicobacter mustelae                           [@B41]
      *Mycobacterium* spp.                            [@B42]
  Fungi                                               
      Pneumocystis jirovecii                          [@B43]

MODELS, GENOMES, AND OMICS {#s1}
==========================

The first transgenic ferret was produced by somatic cell nuclear transfer (SCNT) to oocyte recipient cells in 2006 ([@B9]). This technique was then combined with adeno-associated virus-mediated gene targeting of the cystic fibrosis transmembrane conductance regulator (CFTR) gene to generate a transgenic ferret model of cystic fibrosis and create the first reported ferret genomic bacterial artificial chromosome library ([@B10]). More recently, CRISPR/Cas9-mediated genome editing techniques were applied to ferrets to develop a model organism to study X-linked, double cortin-related lissencephaly spectrum ([@B11]). In addition to genetically modified ferrets, research groups have described the development of immunocompromised ([@B12]), pregnant ([@B13]), aged ([@B14]), and diet-induced obese (DIO \[unpublished data\]) models to understand disease in high-risk populations. It is likely that new models and transgenic animals will be developed in the near future.

The sequencing of the ferret genome ([@B15]) was instrumental in advancing functional genomic analysis. Numerous groups developed reagents to monitor gene-specific mRNA expression levels via TaqMan-based or Sybr green-based real-time reverse transcription-PCR assays for a plethora of targets. Many of these primers are available free of charge through the National Institute of Allergy and Infectious Diseases (NIAID) established BEI Resources (<https://www.beiresources.org/Home.aspx>). Bruder et al. described the development of an expression microarray platform that included the identification of 41 genes with consistent baseline transcription profiles across tissues that could be used as housekeeping genes ([@B16]). Our group developed and is validating a FLUIDIGM panel with 144 distinct immune response and lung injury and repair genes. Beyond transcription, Tisoncik-Go et al. described an integrated omics analysis that profiles lipids, metabolites, and proteins in the respiratory compartments of influenza virus-infected ferrets ([@B17]). Combined, these tools provide powerful resources to the research community.

THE NEXT FRONTIER: THE IMMUNE RESPONSE {#s2}
======================================

Despite its relevance for biomedical research, there are limitations of the ferret model for immunologic studies due to the dearth of reagents. Screening of commercially available antibodies for cross-reactivity with markers on innate and adaptive cell subsets and cytokines in ferrets has yielded limited success ([Table 2](#tab2){ref-type="table"}). To resolve this, a group of researchers from around the world are working together to develop validated reagents and assays to improve our understanding of the innate and adaptive immune responses in the ferret.

###### 

Commercial kits and immunologic reagents tested in the ferret model

  --------------------------------------------------------------------------------------------------------------------------------------------------------------
  Product type\                                   Specificity   Clone       Isotype    Host     Vendor                       Application        Reference(s)
  and name[^a^](#ngtab2.1){ref-type="table-fn"}                                                                                                 
  ----------------------------------------------- ------------- ----------- ---------- -------- ---------------------------- ------------------ ----------------
  Commercial kits                                                                                                                               

      LIVE/ DEAD Fixable Aqua dead\                                                             Thermo/Fisher                Flow cyt           [@B18]
  cell stain                                                                                                                                    

      IFN-γ ELISpot basic (HRP) kit                                                             MabTech                      ELISpot            [@B18]

  Primary antibodies                                                                                                                            

      CD44                                        Mouse         IM7         IgG2b, κ   Rat      BD Pharmingen                Flow cyt           [@B19]

      IL-4                                        Bovine        CC303       IgG2a      Mouse    Bio-Rad                      Flow cyt           [@B19]

      IFN-γ                                       Bovine        CC302       IgG1       Mouse    Bio-Rad                      Flow cyt           [@B19]

      IFN-γ                                       Mouse         XMG1.2      IgG1, κ    Rat      BD Pharmingen                Flow cyt           [@B19]

      TNF                                         Mouse         MP6-XT22    IgG1       Rat      BD Pharmingen                Flow cyt           [@B19]

      Thy1.1                                      Rat           OX-7        IgG1, κ    Mouse    BD Pharmingen                Flow cyt           [@B19]

      CD11b                                       Mouse/human   M1/70       IgG2b, κ   Rat      BD Pharmingen or BioLegend   Flow cyt           [@B18], [@B19]

      CD8a                                        Human         OK-T8       IgG2a      Mouse    eBioscience/Tonbo            Flow cyt           [@B18], [@B19]

      CD4                                         Ferret        02          IgG1       Mouse    Sino Biological              Flow cyt           [@B18], [@B19]

      MHC-II                                      Human         L243        IgG2a, κ   Mouse    BioLegend                    Flow cyt           [@B18]

      IgA, IgM, IgG                               Ferret                    Poly       Goat     LSBio                        Flow cyt           [@B18]

      CD59                                        Mouse         AL-21       IgM, κ     Rat      BD Pharmingen                Flow cyt           [@B18]

      CD79a                                       Human         HM47        IgG1, κ    Mouse    eBioscience                  Flow cyt           [@B18]

      CD20                                        Ferret        71          IgG        Rabbit   Sino Biological              Flow cyt           [@B18]

      CD3                                         Human         IS5033      Poly       Rabbit   Dako                         IHC                [@B44]

      Lysozyme                                    Human         A0099       Poly       Rabbit   Dako                         IHC                [@B44]

      CD20                                        Human         RB-9013-P   Poly       Rabbit   Thermo (Fisher)              IHC                [@B44]

      CD79a                                       Human         HM57        IgG1, κ    Mouse    Dako                         IHC                [@B44]

      MHC-II                                      Human         TAL 1B5     IgG1, κ    Mouse    Dako                         IHC                [@B44]

      CD3                                         Human         PC3/188A    IgG1, κ    Mouse    Santa Cruz Biotech           Flow cyt           [@B45]

      IFN-γ (capture Ab)                          Cow           CC302       IgG1       Mouse    Bio-Rad                      ELISpot/flow cyt   [@B45]

      IFN-γ biotinylated (detection Ab)           Dog                       Poly       Goat     R&D Systems                                     [@B45], [@B46]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: HRP, horseradish peroxidase conjugate; TNF, tumor necrosis factor; Ab, antibody; Flow cyt, flow cytometry; IHC, immunohistochemistry.

To date, recombinant proteins representing a range of intrinsic, innate, and adaptive immune markers are under development, and some are already available from commercial sources ([@B18], [@B19]). These include type I and III interferons (IFNs), RIG-I and Toll-like receptors, cytokines, and chemokines, as well as cell surface markers for immune and nonimmune cells. In terms of adaptive immune responses, Kirchenbaum and Ross recently developed a monoclonal antibody against the ferret B cell receptor light chain that is useful in distinguishing kappa versus lambda B cell responses ([@B20], [@B21]). Enzyme-linked immunosorbent spot (ELISpot) and flow cytometric assays have been developed to quantify the isotypes of antibody-secreting cells (IgG or IgA) ([@B22]), pan-B cells (CD20^+^, CD79α^+^), and Ig^+^ B cells ([@B18], [@B19]). T cell phenotyping has been limited to quantification of overall CD3^+^ T cells, including CD4^+^ and CD8^+^ subsets, by flow cytometric assays and identification of antigen-specific effector responses by detecting IFN-γ secretion in flow-based intracellular cytokine secretion assays or ELISpot assays ([@B18]). An *in vivo* depletion of CD8 T cells using a cross-reactive human monoclonal antibody has been shown to delay influenza virus clearance ([@B23]). To increase our toolbox, the Centers for Excellence in Influenza Research and Surveillance (CEIRS) network has undertaken a large project to rapidly produce monoclonal antibodies and develop assays to support the universal influenza vaccine initiative ([@B24]). Antibodies in production include B cell markers (CD83, CD86, CD95, CD19, CD20, CD25, CD27, CD38, CD138, CXCR5, and FcR), T cell markers (CD4, CCR7, CD3e, CD40, CD40L, CD44, CD62L, CD69, CD103, PD-1, CXCR3, interleukin-7 receptor \[IL-7R\], and IL-15Ra) and others (CXCR4, CD140, IL-2, IL-21, and IL-4). These much-needed reagents will facilitate efforts to establish immunologic assays to interrogate the innate and adaptive immune responses to infection and vaccination at the level of detail that is routinely applied to studies of mouse or human immunology. Importantly, the ferret model will allow correlates of protection to be established after vaccination and infection in conjunction with transmission studies, which are not available in the mouse models. Additionally, the longer life span of the ferret relative to the mouse will allow analysis of the evolution of the immune response to sequential infection and/or vaccination ([@B25]), permitting more accurate modeling of the immune response in humans.

WAYS FORWARD {#s3}
============

While there has been exciting progress, much work remains to move the ferret model forward. Toward this goal, the CEIRS group has produced fibroblasts and primary nasal and tracheal epithelial cells and cell lines, established a repository of defined tissues and cell types ([Table 3](#tab3){ref-type="table"}), and are working with the J. Craig Venter Institute to define the ferret major histocompatibility complex (MHC). An exciting achievement is the completion of the PacBio sequencing of the ferret MHC (Granger Sutton, personal communication). While these are important steps, the ultimate goal is to provide the biomedical research community with validated reagents and protocols they can trust to ensure the rigor and reproducibility in experiments utilizing the ferret model. In support of this goal, many of the reagents created through the CEIRS network will be made publicly available through the CEIRS Data Processing and Coordinating Center (DPCC) website (<http://www.niaidceirs.org/resources/ceirs-reagents/>).

###### 

Current tissue repository

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Tissue                                                           Sample[^a^](#ngtab3.1){ref-type="table-fn"}                  Sample forms                                                 Sex                                        Comment
  ---------------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------ ------------------------------------------
  Lung                                                             Brochioalveolar fluid                                                                                                     M                                          Influenza virus infected

  Upper right, middle right, lower right, upper left, lower left   Single-cell suspension; homogenate; whole tissue; Trizol;\   M and F                                                      Influenza virus infected and noninfected   
                                                                   paraffin-embedded tissue                                                                                                                                             

  Blood                                                            PBMC                                                         Fluid; isolated cells; RNAlater                              M and F                                    Influenza virus infected and noninfected

  Plasma                                                                                                                        M                                                            Noninfected                                

  Sera                                                                                                                          M                                                            Influenza virus infected and noninfected   

  Nasal fluid (wash)                                               NA                                                           Fluid                                                        M                                          Influenza virus infected and noninfected

  Spleen                                                           NA                                                           Whole tissue; single-cell suspension; homogenate;            M and F                                    Influenza virus infected and noninfected

  Trachea                                                          NA                                                           Whole tissue; single-cell suspension; homogenate; RNAlater   M and F                                    Influenza virus infected and noninfected

  Mediastinal lymph node                                           NA                                                           Whole tissue                                                 M and F                                    Influenza virus infected
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PBMC, peripheral blood mononuclear cells; NA, not applicable.
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